ANIX Anixa Biosciences, Inc.

NASDAQ
$2.78

Anixa Biosciences, Inc. (ANIX) is expected to report earnings on December 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.08 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -4.8% since its last earnings release on September 9, 2026.

Anixa Biosciences Reported In-line with Estimates
Wednesday, September 9, 2026 · 12:00 AM ET
Earnings Date
4th Quarter, Oct 2026
Dec 9
Wednesday · After Close
Earnings Whisper
-
vs ($0.08)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.74

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Anixa Biosciences, Inc.

Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.